(fda.gov): The US Food and Drug Administration has unveiled a new source of information for patients and health care professionals on the safety of recently approved drugs and biologics. Summaries of FDA safety analyses on recently approved products will now be periodically prepared and posted on FDA’s website along with a brief discussion of the steps FDA is taking to address any identified safety issues.
Category: Articles
Click here